Posted On: 11/16/2015 9:48 AM
MASTERS– A study of investigational drug for testosterone suppression in prostate cancer
1. Male age 18 or over
2. Meet the criteria for testosterone supression
3. Diagnosis of prostate cancer
Sponsored by: BHR
Length of Study: 1 year
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 7
Our Investigator for this study is Christopher Pieczonka, M.D.